Narrow search
Showing 1 - 8 of 8
Cover Image
Islamic insurance prospects in Tunisia in the wake of the Jasmine revolution
Echchabi, Abdelghani; Ayinde Olorogun, Lukman; Azouzi, … - In: Journal of Islamic Accounting and Business Research 5 (2014) 1, pp. 15-28
Purpose – The purpose of the study is to examine the willingness (or otherwise) of the Tunisian customers to adopt Islamic insurance services (takaful) and to determine the factors that influence their decisions. Design/methodology/approach – Hundred questionnaires are randomly distributed...
Persistent link: https://www.econbiz.de/10014874632
Cover Image
Income disparities in healthcare use remain after controlling for healthcare need : evidence from Swedish register data on psoriasis and psoriatic arthritis
Löfvendahl, Sofia; Jöud, Anna; Petersson, Ingemar F.; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 3, pp. 447-462
Persistent link: https://www.econbiz.de/10011946873
Cover Image
Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
Balogh, Orsolya; Brodszky, Valentin; Gulácsi, László; … - In: The European Journal of Health Economics 15 (2014) 1, pp. 101-109
provides cost-of-illness data in psoriasis involving patients with BST. </AbstractSection> Copyright Springer-Verlag Berlin …
Persistent link: https://www.econbiz.de/10010993828
Cover Image
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
Herédi, Emese; Rencz, Fanni; Balogh, Orsolya; … - In: The European Journal of Health Economics 15 (2014) 1, pp. 111-119
clinical variables, our model included health service utilisation variables related to psoriasis, and explained higher …
Persistent link: https://www.econbiz.de/10010993829
Cover Image
Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
Knight, Christopher; Mauskopf, Josephine; Ekelund, Mats; … - In: The European Journal of Health Economics 13 (2012) 2, pp. 145-156
Persistent link: https://www.econbiz.de/10010845772
Cover Image
Comparative Effectiveness Without Head-to-Head Trials: A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept
Signorovitch, James E.; Wu, Eric Q.; Yu, Andrew P.; … - In: PharmacoEconomics 28 (2010) 10, pp. 935-945
a comparison of adalimumab and etanercept for the treatment of psoriasis. IPD from trials of adalimumab versus placebo … trials. Symptom improvements of ≥75% and ≥90% (as measured by the Psoriasis Area and Severity Index &lsqb;PASI&rsqb; score at … psoriasis. …
Persistent link: https://www.econbiz.de/10008519891
Cover Image
The Cost Effectiveness of Tapered versus Abrupt Discontinuation of Oral Cyclosporin Microemulsion for the Treatment of Psoriasis
Hakkaart-van Roijen, Leona; Verboom, Paul; Redekop, W. Ken - In: PharmacoEconomics 19 (2001) 5, pp. 599-608
cyclosporin in patients with chronic plaque psoriasis. Methods: A cost-effectiveness analysis was performed in parallel with a … plaque psoriasis inadequately controlled with topical treatment. Study perspective: The study was conducted from a societal … cyclosporin in patients with chronic plaque psoriasis. …
Persistent link: https://www.econbiz.de/10005590279
Cover Image
The Burden of Moderate to Severe Psoriasis: An Overview
Raho, Giovanna; Koleva, Daniela Mihajlova; Garattini, Livio - In: PharmacoEconomics 30 (2012) 11, pp. 1005-1013
Psoriasis is a chronic, immune-mediated skin disorder that affects 1-3% of the general population worldwide. While … considered a non-life-threatening disease, psoriasis represents a social and financial burden for patients and the healthcare …, patients with a diagnosis of psoriasis usually need lifelong care, which also means a lifetime of expenses. We aimed to conduct …
Persistent link: https://www.econbiz.de/10010579446